Medivention Limited - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 06993090 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 AUGUST 2019

FOR

MEDIVENTION LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

T Y Kwong

REGISTERED OFFICE:

11 Barn Hill

Wembley Park

Wembley

London

Middlesex

HA9 9LA

REGISTERED NUMBER:

06993090 (England and Wales)

ACCOUNTANTS:

Civvals Limited

50 Seymour Street

London

W1H 7JG

FIXED ASSETS

Tangible assets

4

738

1,269

CURRENT ASSETS

Stocks

6,730

7,730

Debtors

5

2,557

3,790

Cash at bank

1,376

1,195

10,663

12,715

CREDITORS

Amounts falling due within one year

6

9,825

10,075

NET CURRENT ASSETS

838

2,640

TOTAL ASSETS LESS CURRENT LIABILITIES

1,576

3,909

CREDITORS

Amounts falling due after more than one year

7

22,558

20,759

NET LIABILITIES

(20,982

)

(16,850

)

CAPITAL AND RESERVES

Called up share capital

1,000

1,000

Retained earnings

(21,982

)

(17,850

)

SHAREHOLDERS' FUNDS

(20,982

)

(16,850

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2019 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 July 2020 and were signed by:

T Y Kwong - Director

1.	STATUTORY INFORMATION

Medivention Limited is a private company, limited by shares , registered in England and Wales. The company's

registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,

value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on reducing balance and 20% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow

moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to

the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or

substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance

sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from

those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that

have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the

timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they

will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development

Expenditure on research and development is written off in the year in which it is incurred.

Going concern

The accounts have been prepared as a going concern on the basis that the director and shareholders will continue

to support the company for the foreseeable future.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2018 - NIL).

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 September 2018

and 31 August 2019

2,871

DEPRECIATION

At 1 September 2018

1,602

Charge for year

531

At 31 August 2019

2,133

NET BOOK VALUE

At 31 August 2019

738

At 31 August 2018

1,269

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2019

2018

£

£

Other debtors

2,557

3,790

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2019

2018

£

£

Other creditors

9,825

10,075

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2019

2018

£

£

Other creditors

22,558

20,759

8.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

Included in other creditors due after more than one year are amounts £22,558 (2018-£20,759) due to the

director, T Y Kwong. The director continues to support the company to meet the day to day running of the

business and will do so until it reaches profitability and becomes cash positive.

9.	RELATED PARTY DISCLOSURES

Included in other debtors under note 5 is an amount owed by Urotopia Limited amounting to £1,360 (2018:

£1,360) to the company.

Urotoipa Limited is under the common control of the director Mr T W Kwong.